Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: Long term results of a 'donor' versus 'no donor' comparison

Leukemia

Volumn 23, Issue 1, 2009, Pages 194-196

  Mohty, M ^a,b,c   de Lavallade, H ^a   El Cheikh, J ^a   Ladaique, P ^a   Faucher, C ^a   Furst S ^a   Vey, N ^a   Coso, D ^a   Stoppa, A M ^a   Gastaut, J A ^a   Chabannon, C ^a   Blaise, D ^a,b,c  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DONOR SELECTION; HLA MATCHING; HUMAN; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REDUCED INTENSITY CONDITIONING; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VALIDATION PROCESS;

EID: 58249116979     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.164     Document Type: Letter

References (10)

1. Sorror ML, Giralt S, Sandmaier BM, De Lima M, Shahjahan M, Maloney DG et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: Combined FHCRC and MDACC experiences. Blood 2007; 110: 4606-4613.
2. Champlin R, Khouri I, Kornblau S, Molldrem J, Giralt S. Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect. Oncology (Huntingt) 1999; 13: 621-628; discussion 631, 635-638, 641.
3. Storb R. Can reduced-intensity allogeneic transplantation cure older adults with AML? Best Pract Res Clin Haematol 2007; 20: 85-90.
4. Lazarus HM, Rowe JM. Reduced-intensity conditioning for acute myeloid leukemia: Is this strategy correct. Leukemia 2006; 20: 1673-1682.
5. Martino R, Iacobelli S, Brand R, Jansen T, van Biezen A, Finke J et al. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. Blood 2006; 108: 836-846.
6. Blaise D, Vey N, Faucher C, Mohty M. Current status of reduced-intensity- conditioning allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica 2007; 92: 533-541.
7. Shimoni A, Nagler A. Allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia in first complete remission: New answers for an old question. Leukemia 2005; 19: 891-893.
8. Mohty M, de Lavallade H, Ladaique P, Faucher C, Vey N, Coso D et al The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: A donor vs no donor comparison. Leukemia 2005; 19: 916-920.
9. Hegenbart U, Niederwieser D, Sandmaier BM, Maris MB, Shizuru JA, Greinix H et al. Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors. J Clin Oncol 2006; 24: 444-453.
10. Valcarcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB et al. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: Chronic graft-versus-host disease is the strongest factor improving survival. J Clin Oncol 2008; 26: 577-584.